Inventor · disambiguated record
Donald P. Mcdonnell
Also filed as: MCDONNELL DONALD · MCDONNELL DONALD P
22 granted patents·17 pending applications·522 citations·filing 1992–2025
95Inventor score
Files withUNIV DUKE31BAYLOR COLLEGE MEDICINE3KATZENELLENBOGEN JOHN1LIGAND PHARM INC1MCDONNELL DONALD P1
Top patents by PatentIndex Score
39 records- 0195US9421264B2Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2014·Granted Aug 23, 2016·16 cites·28 claims
- 0294US11980597B2Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2023·Granted May 14, 2024·2 cites·9 claims
- 0394US11974983B2Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2022·Granted May 7, 2024·3 cites·27 claims
- 0494US10258604B2Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2018·Granted Apr 16, 2019·12 cites·17 claims
- 0594US10071066B2Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2016·Granted Sep 11, 2018·7 cites·10 claims
- 0692US11951080B2Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2022·Granted Apr 9, 2024·1 cites·11 claims
- 0792US11497730B2Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2019·Granted Nov 15, 2022·7 cites·32 claims
- 0892US10905659B2Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2019·Granted Feb 2, 2021·8 cites·19 claims
- 0992US5935934AMutated steroid hormone receptors, methods for their use and molecular switch for gene therapyBAYLOR COLLEGE MEDICINE·Filed 1995·Granted Aug 10, 1999·99 cites·9 claims
- 1092US5874534AMutated steroid hormone receptors, methods for their use and molecular switch for gene therapyBAYLOR COLLEGE MEDICINE·Filed 1995·Granted Feb 23, 1999·100 cites·18 claims
- 1191US10420734B2Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2015·Granted Sep 24, 2019·9 cites·29 claims
- 1290US12414924B2Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2024·Granted Sep 16, 2025·0 cites·19 claims
- 1390US11779552B2Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2021·Granted Oct 10, 2023·1 cites·14 claims
- 1489US12263142B2Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2023·Granted Apr 1, 2025·0 cites·14 claims
- 1588US5364791AProgesterone receptor having C. terminal hormone binding domain truncationsVEGETO ELISABETTA·Filed 1992·Granted Nov 15, 1994·178 cites·17 claims
- 1688US2025064757A1Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2024·Application pending·0 cites
- 1786US5506102AMethods of using the A form of the progesterone receptor to screen for antagonists of steroid intracellar receptor-mediated transcriptionLIGAND PHARM INC·Filed 1993·Granted Apr 9, 1996·72 cites·19 claims
- 1886US2024197654A1Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2024·Application pending·0 cites
- 1979US2025090496A1Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2024·Application pending·0 cites
- 2077US2020121621A1Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2019·Application pending·0 cites
- 2176US2025205180A1Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2025·Application pending·0 cites
- 2272US2021361596A1Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2020·Application pending·0 cites
- 2371US2020368184A1Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2020·Application pending·0 cites
- 2471US2019083421A1Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2018·Application pending·0 cites
- 2569US2019231718A1Treatment of breast cancerUNIV DUKE·Filed 2017·Application pending·0 cites
- 2669US2018098963A1Lasofoxifene treatment of breast cancerUNIV DUKE·Filed 2017·Application pending·0 cites
- 2766US2020009084A1Method of treating cancer using selective estrogen receptor modulatorsUNIV DUKE·Filed 2019·Application pending·0 cites
- 2864US7307102B2Method of preventing or treating estrogen-dependent diseases and disordersUNIV DUKE·Filed 2003·Granted Dec 11, 2007·6 cites·8 claims
- 2963US2024398831A1Compositions comprising small molecule regulators of tumor immunity and methods of using sameUNIV DUKE·Filed 2022·Application pending·0 cites
- 3057US12158399B2CaMKK2 inhibitor compositions and methods of using the sameUNIV DUKE·Filed 2017·Granted Dec 3, 2024·0 cites·9 claims
- 3152US2007134349A1Methods of treating hematological malignanciesUNIV DUKE·Filed 2006·Application pending·0 cites
- 3251US9999620B2CaMKK-β as a target for treating cancerUNIV DUKE·Filed 2016·Granted Jun 19, 2018·0 cites·12 claims
- 3345US7238793B2Estrogen receptor modulatorsUNIV DUKE·Filed 2002·Granted Jul 3, 2007·0 cites·10 claims
- 3444US2010034778A1Stem cellsUNIV DUKE·Filed 2006·Application pending·0 cites
- 3542US2013253035A1Camkk-beta as a target for treating cancerMCDONNELL DONALD P·Filed 2011·Application pending·0 cites
- 3640US2018303807A1Androgen receptor ligandsKATZENELLENBOGEN JOHN·Filed 2016·Application pending·0 cites
- 3737US6599698B1Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapyBAYLOR COLLEGE MEDICINE·Filed 1998·Granted Jul 29, 2003·1 cites·32 claims
- 3835US9868705B2Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancerUNIV ILLINOIS·Filed 2014·Granted Jan 16, 2018·0 cites·31 claims
- 3935US2019271703A1Biomarkers and treatments for metastatic cancerUNIV DUKE·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →